UNSPSC 41202064: Toxoplasma gondiiserological reagents

In this classification, Toxoplasma gondii serological reagents are devices used in test to identify specific Toxoplasma gondii antibodies in serum. US FDA regulates Toxoplasma gondii serological reagents under 21 CFR 866.3780 and under FDA product code GMN.

UNSPSC 41202064 Toxoplasma gondiiserological reagents is a Commodity code that does not reflect the work state and local governments are actually buying under this tag. The recent solicitations posted under this code span offender drug testing services, HIV rapid test kits, HIV and Syphilis diagnostic reagents, forensic specimen analysis, pool maintenance, and general clinical laboratory services — none of which are toxoplasma serological reagents. The code appears to be a taxonomy mismatch in state and local procurement systems rather than an active category for the reagent product it nominally describes. Issuing bodies using this code include county criminal justice departments, municipal public health agencies, state health laboratories, corrections authorities, and educational institutions, but the work they are actually procuring falls outside serology for toxoplasma.

Recent activity clusters around HIV and Syphilis testing: the Illinois Department of Public Health issued an emergency procurement (26482DPHOFCDIB52638, due August 18, 2026) for Abbott HIV and Syphilis reagents, calibrators, controls, and maintenance services for its Carbondale Laboratory at $38,079.50; the City of Austin posted an IFB (IFB9100AAM1023, due July 17, 2026) for Abbott Determine HIV 1/2 test kits for its Public Health Program; and the Illinois Department of Public Health Division of Laboratories issued a five-year IFB (26482DPHOFCDIB50489, due March 16, 2026) for automated combination screening technology covering Hepatitis B, Hepatitis C, HIV-1/HIV-2, and Syphilis assays with approximately 30,000 annual tests across multiple pathogens. Collin County Community Supervision and Corrections Department solicited drug testing services (RFP 2026-327, due July 23, 2026) with an estimated annual value of $600,000 for specimen collection and immunoassay screening with confirmatory testing. The code shows activity in Texas and Illinois, with Texas Department of Criminal Justice and local corrections agencies seeking forensic and toxicology laboratory testing. This code does not reflect genuine procurement of toxoplasma serological reagents and warrants realignment in issuing-body systems or exclusion from active monitoring.